Dr. Lal Path Labs Ltd. has informed the Exchange about Schedule of meet
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Lal PathLabs has informed the stock exchanges about an upcoming analyst/institutional investor meeting scheduled for March 17, 2026. The meeting is with Goldman Sachs as part of their India Healthcare Services Virtual Tour Group, conducted virtually in a one-on-one format. The company has clarified that no Unpublished Price Sensitive Information (UPSI) will be shared during this meeting. This is a routine disclosure under SEBI's Listing Regulations to maintain transparency about investor interactions.
This is a routine regulatory disclosure with no direct material impact on the stock. The meeting with Goldman Sachs shows continued institutional interest in the stock, but since no UPSI will be discussed, no immediate price catalyst is expected from this engagement.